Literature DB >> 23205585

Mimicking the microenvironment in chronic lymphocytic leukaemia - where does the journey go?

Daniela Asslaber, Eva M Grössinger, Tamara Girbl, Sebastian W Hofbauer, Alexander Egle, Lukas Weiss, Richard Greil, Tanja N Hartmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23205585     DOI： 10.1111/bjh.12151

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  11 in total

1.  Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors.

Authors:  Sylvia Ganghammer; Julia Gutjahr; Evelyn Hutterer; Peter W Krenn; Susanne Pucher; Claudia Zelle-Rieser; Karin Jöhrer; Maikel Wijtmans; Rob Leurs; Martine J Smit; Valter Gattei; Richard Greil; Tanja N Hartmann
Journal:  Haematologica       Date:  2015-11-20       Impact factor: 9.941

2.  B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.

Authors:  Daniela Asslaber; Yuan Qi; Nicole Maeding; Markus Steiner; Ursula Denk; Jan Philip Höpner; Tanja Nicole Hartmann; Nadja Zaborsky; Richard Greil; Alexander Egle
Journal:  Blood       Date:  2019-11-14       Impact factor: 22.113

3.  Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.

Authors:  Julia C Gutjahr; Eva Szenes; Lisa Tschech; Daniela Asslaber; Michaela Schlederer; Simone Roos; Xiaobing Yu; Tamara Girbl; Christina Sternberg; Alexander Egle; Fritz Aberger; Ronen Alon; Lukas Kenner; Richard Greil; Veronique Orian-Rousseau; Tanja N Hartmann
Journal:  Blood       Date:  2018-01-19       Impact factor: 22.113

Review 4.  How cell death shapes cancer.

Authors:  V Labi; M Erlacher
Journal:  Cell Death Dis       Date:  2015-03-05       Impact factor: 8.469

5.  The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.

Authors:  Sebastian W Hofbauer; Peter W Krenn; Josefina Piñόn Hofbauer; Susanne Pucher; Daniela Asslaber; Alexander Egle; Tanja N Hartmann; Richard Greil
Journal:  Br J Haematol       Date:  2015-07-06       Impact factor: 6.998

6.  CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms.

Authors:  Evelyn Hutterer; Daniela Asslaber; Chiara Caldana; Peter W Krenn; Antonella Zucchetto; Valter Gattei; Richard Greil; Tanja N Hartmann
Journal:  Br J Haematol       Date:  2014-10-17       Impact factor: 6.998

7.  Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade.

Authors:  E M Grössinger; L Weiss; S Zierler; S Rebhandl; P W Krenn; E Hinterseer; J Schmölzer; D Asslaber; S Hainzl; D Neureiter; A Egle; J Piñón-Hofbauer; T N Hartmann; R Greil; H H Kerschbaum
Journal:  Leukemia       Date:  2014-01-20       Impact factor: 11.528

8.  CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model.

Authors:  T Kocher; D Asslaber; N Zaborsky; S Flenady; U Denk; P Reinthaler; M Ablinger; R Geisberger; J W Bauer; M Seiffert; T N Hartmann; R Greil; A Egle; J Piñón Hofbauer
Journal:  Leukemia       Date:  2015-11-02       Impact factor: 11.528

9.  Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia.

Authors:  Rebecca Voltan; Erika Rimondi; Elisabetta Melloni; Gian Matteo Rigolin; Fabio Casciano; Maria Vittoria Arcidiacono; Claudio Celeghini; Antonio Cuneo; Giorgio Zauli; Paola Secchiero
Journal:  Oncotarget       Date:  2016-10-25

Review 10.  The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.

Authors:  Gabriele Brachtl; Josefina Piñón Hofbauer; Richard Greil; Tanja Nicole Hartmann
Journal:  Ann Hematol       Date:  2013-11-28       Impact factor: 3.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.